Published Dec 23, 2014 |
150 Pages |
Pub ID: KLI5421818
In the past, cancer treatments could be painful, invasive and damage the patient's body. Now there are many novel techniques available for cancer patients that are not as invasive and detrimental to the body as a whole. Gene therapy is the most prominent new form of these alternative treatments.
This report, The Market for Personalized Gene Therapy Treatments For Cancer provides a complete review of the market potential for relatively new approach in cancer research, that of changing genes in the place of using a surgical treatment or a drug product. In essence, gene therapies replace an improper gene with a normal one. They also might change the response of a gene. There are many different approaches within gene therapy.
This report discusses those treatments and estimates market size and market potential for personalized medicine using gene therapy. It includes market forecasts for the following types of cancer:
Head & Neck
In addition the report provides:
Discussion of Somatic vs. Germ Line Gene Therapy
Overview of Gene Therapy
Overall Market Size and Forecast
Cancer Therapeutic Market Totals
Companies considered in this study consist of companies which have trials Phase I trials through Phase III drug development and have development that is demonstrating efficacy. These include:
Takara Bio, Inc.
VBL Therapeutics Ltd.
Chengdu Shi Endor Biological Engineering Technology Co., Ltd.
Cold Genesys, Inc.
OncoSec Medical, Inc.
Sevion Therapeutics, Inc.
SynerGene Therapeutics, Inc.
Ziopharm Oncology, Inc.
Bellicum Pharmaceuticals, Inc.
We were unable to search inside this report.
No results matched your search criteria.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend").
Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.